Receptor-based biomimetic NVP/DMA contact lenses for loading/eluting carbonic anhydrase inhibitors

Journal of Membrane Science

Volumn 383, Issue 1-2, 2011, Pages 60-69

  Ribeiro, Andreza ^a,b   Veiga, Francisco ^a   Santos, Delfim ^a,c   Torres Labandeira, Juan J ^b   Concheiro, Angel ^b   Alvarez Lorenzo, Carmen ^b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^c UNIVERSITY OF PORTO   (Portugal)

Author keywords

Bioinspired drug delivery; CAI; Combination product; Molecular imprinting; Soft contact lens

Indexed keywords

ACRYLAMIDES; ACTIVE SITE; BIOMIMETIC PRINCIPLES; COMBINATION PRODUCTS; CYTOCOMPATIBILITY; DELIVERY SYSTEMS; DRUG LOADING; FUNCTIONAL MONOMER; INTRA OCULAR PRESSURE; MOLECULAR IMPRINTING; N ,N-DIMETHYLACRYLAMIDE; N VINYLPYRROLIDONE; NATURAL RECEPTORS; OCULAR DELIVERY; PARTITION COEFFICIENT; SIDE EFFECT; SOFT CONTACT LENS; VISIBLE LIGHT; WATER UPTAKE; ZINC CONTENT; ZINC SALTS;

AMIDES; BIOMIMETICS; CARBONIC ANHYDRASE; COMPUTER AIDED INSTRUCTION; CONTACT LENSES; DRUG DELIVERY; DRUG INTERACTIONS; LIGHT; ORGANIC POLYMERS; SALTS; ZINC;

HYDROGELS;

1 VINYL 2 PYRROLIDINONE; 1 VINYLIMIDAZOLE DERIVATIVE; 4 VINYLIMIDAZOLE; ACETAZOLAMIDE; ACRYLAMIDE; DRUG RECEPTOR; ETHOXZOLAMIDE; IMIDAZOLE DERIVATIVE; MONOMER; N HYDROXYETHYL ACRYLAMIDE; N,N DIMETHYLACRYLAMIDE; UNCLASSIFIED DRUG; ZINC DERIVATIVE; ZINC ION;

ABSORPTION; ARTICLE; BINDING AFFINITY; BIOCOMPATIBILITY; BIOMIMETICS; CHORIOALLANTOIS; CONTACT LENS; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RELEASE; ENZYME ACTIVE SITE; FIBROBLAST; FLOW KINETICS; HYDROGEL; LIGHT; NONHUMAN; PARTITION COEFFICIENT; POLYMERIZATION; PRIORITY JOURNAL; SYNTHESIS; VISCOELASTICITY; WATER TRANSPORT;

EID: 80053454152     PISSN: 03767388     EISSN: 18733123     Source Type: Journal    
DOI: 10.1016/j.memsci.2011.08.030     Document Type: Article

References (52)

1. Mano J.F., Reis R.L. Some trends on how one can learn from and mimic nature in order to design better biomaterials. Mater. Sci. Eng. C 2005, 25:93-95.
2. Bhushan B. Biomimetics: lessons from nature - an overview. Philos. Trans. R. Soc. A 2009, 367:1445-1486.
3. C. Alvarez-Lorenzo, F. Yañez-Gomez, A. Concheiro, Modular biomimetic drug delivery systems, in: S. Dumitriu, V. Popa (Eds.), Polymeric Biomaterials, 3rd edition, Taylor & Francis, London, 2012.
4. Ranney D.F. Biomimetic transport and rational drug delivery. Biochem. Pharmacol. 2000, 59:105-114.
5. Dillow A.K., Lowman A.M. Biomimetic Materials and Design 2004, Marcel Dekker, New York.
6. Youan B.B. Chronopharmaceutics: gimmick or clinically relevant approach to drug delivery?. J. Control. Release 2004, 98:337-353.
7. Vauthier C., Labarre D. Modular biomimetic drug delivery systems. J. Drug Deliv. Sci. Technol. 2008, 18:59-68.
8. Alvarez-Lorenzo C., Concheiro A. Intelligent drug delivery systems: polymeric micelles and hydrogels. Mini-Rev. Med. Chem. 2008, 8:1065-1074.
9. Bayer C.L., Peppas N.A. Advances in recognitive, conductive and responsive delivery systems. J. Control. Release 2008, 132:216-221.
10. Keegan M.E., Whittum-Hudson J.A., Saltzman W.M. Biomimetic design in microparticulate vaccines. Biomaterials 2003, 24:4435-4443.
11. Lacik I. Polymer chemistry in diabetes treatment by encapsulated islets of Langerhans: review to 2006. Aust. J. Chem. 2006, 37:508-524.
12. Kukreja N., Onuma Y., Daemen J., Serruys P.W. The future of drug-eluting stents. Pharmacol. Res. 2008, 57:171-180.
13. Wang Y., Mangipudi S.S., Canine B.F., Hatefi A. A designer biomimetic vector with a chimeric architecture for targeted gene transfer. J. Control. Release 2009, 137:46-53.
14. Venkatesh S., Saha J., Pass S., Byrne M.E. Transport and structural analysis of molecular imprinted hydrogels for controlled drug delivery. Eur. J. Pharm. Biopharm. 2008, 69:852-860.
15. Ali M., Byrne M.E. Controlled release of high molecular weight hyaluronic acid from molecularly imprinted hydrogel contact lenses. Pharm. Res. 2009, 26:714-726.
16. Tanrikulu Y., Schneider G. Pseudoreceptor models in drug design: bridging ligand- and receptor-based virtual screening. Nat. Rev. Drug Discov. 2008, 7:667-677.
17. Byrne M.E., Park K., Peppas N.A. Molecular imprinting within hydrogels. Adv. Drug Deliv. Rev. 2002, 54:149-161.
18. Alvarez-Lorenzo C., Concheiro A., Chuang J., Grosberg A.Y. Imprinting using smart polymers. Smart Polymers: Production, Study and Application in Biotechnology and Biomedicine 2008, 211-245. CRC Press, Boca Raton. I. Galaev, B. Mattiasson (Eds.).
19. Alvarez-Lorenzo C., Concheiro A. Molecularly imprinted polymers for drug delivery. J. Chromatogr. B 2004, 804:231-245.
20. Alvarez-Lorenzo C., Yañez F., Concheiro A. Ocular drug delivery from molecularly-imprinted contact lenses. J. Drug Deliv. Sci. Technol. 2010, 20:237-248.
21. Alvarez-Lorenzo C., Yanez F., Barreiro-Iglesias R., Concheiro A. Imprinted soft contact lenses as norfloxacin delivery systems. J. Control. Release 2006, 113:236-244.
22. Yanez F., Chianella I., Piletsky S.A., Concheiro A., Alvarez-Lorenzo C. Computational modeling and molecular imprinting for the development of acrylic polymers with high affinity for bile salts. Anal. Chim. Acta 2010, 659:178-185.
23. Venkatesh S., Sizemore S.P., Byrne M.E. Biomimetic hydrogels for enhanced loading and extended release of ocular therapeutics. Biomaterials 2007, 28:717-724.
24. Mincione F., Scozzafava A., Supuran C.T. The development of topically acting carbonic anhydrase inhibitors as antiglaucoma agents. Curr. Pharm. Des. 2008, 14:649-654.
25. Hiratani H., Fujiwara A., Tamiya Y., Mizutani Y., Alvarez-Lorenzo C. Ocular release of timolol from molecularly imprinted soft contact lenses. Biomaterials 2005, 26:1293-1298.
26. Li C.C., Chauhan A. Ocular transport model for ophthalmic delivery of timolol through p-HEMA contact lenses. J. Drug Deliv. Sci. Technol. 2007, 17:69-79.
27. Lindskog S. Structure and mechanism of carbonic anhydrase. Pharmacol. Ther. 1997, 74:1-20.
28. Di Fiore A., Pedone C., Antel J., Waldeck H., Witte A., Wurl M., Scozzafava A., Supuran C.T., De Simone G. Carbonic anhydrase inhibitors: the X-ray crystal structure of ethoxzolamide complexed to human isoform II reveals the importance of thr200 and gln92 for obtaining tight-binding inhibitors. Bioorg. Med. Chem. Lett. 2008, 18:2669-2674.
29. Ribeiro A., Veiga F., Santos D., Torres-Labandeira J., Concheiro A., Alvarez-Lorenzo C. Bioinspired imprinted hydrogels for the ocular delivery of carbonic anhydrase inhibitor drugs. Biomacromolecules 2011, 12:701-709.
30. Wang Y., Tan G., Zhang S., Guang Y. Influence of water states in hydrogels on the transmissibility and permeability of oxygen in contact lens materials. Appl. Surf. Sci. 2008, 255:604-606.
31. Liu K.J., Gregor H.P. Metal-polyelectrolyte complexes. X. Poly-N-vinylimidazole complexes with zinc (II) and with copper(II) and nitrilotriacetic acid. J. Phys. Chem. 1965, 69:1252-1259.
32. Overberger C.G., Vorchheimer N. Imidazole-containing polymers. Synthesis and polymerization of the monomer 4(5)-vinylimidazole. J. Am. Chem. Soc. 1963, 85:951-955.
33. Alvarez-Lorenzo C., Hiratani H., Gomez-Amoza J.L., Martinez-Pacheco R., Souto C., Concheiro A. Soft contact lenses capable of sustained delivery of timolol. J. Pharm. Sci. 2002, 91:2182-2192.
34. Hagesaether E., Bye R., Sande S.A. Ex vivo mucoadhesion of different zinc-pectinate hydrogel beads. Int. J. Pharm. 2008, 347:9-15.
35. NICEATM-ICCVAM, In vitro test methods for detecting ocular corrosives and severe irritants. (accessed June 2011). http://iccvam.niehs.nih.gov/methods/ocutox/ivocutox/ocu_brd_hetcam.htm.
36. Andersson M., Hedin J., Johansson P., Nordström J., Nydén M. Coordination of imidazoles by Cu(II) and Zn(II) as studied by NMR relaxometry, EPR, far-FTIR vibrational spectroscopy and ab initio calculations: effect of methyl substitution. J. Phys. Chem. A 2010, 114:13146-13153.
37. Tazuke S., Okamura S. The π-π* transition spectra and polymerizability of vinyl compounds complexed with zinc salts. J. Polym. Sci. Polym. Lett. 1967, 5:95-99.
38. Fant C., Handa P., Nydén M. Complexation chemistry for tuning release from polymer coatings. J. Phys. Chem. B 2006, 110:21808-21815.
39. Mayo-Pedrosa M., Alvarez-Lorenzo C., Concheiro A. Thermorheological and glass transition properties of PNIPA/PVP and PNIPA/Carbopol blends. J. Therm. Anal. Calorim. 2004, 77:681-693.
40. Mullarney M., Seery T., Weiss R. Drug diffusion in hydrophobically modified N,N-dimethylacrylamide hydrogels. Polymer 2006, 47:3845-3855.
41. Alvarez-Lorenzo C., Hiratani H., Concheiro A. Contact lenses for drug delivery: achieving sustained release with novel systems. Am. J. Drug Deliv. 2006, 4:131-151.
42. Hermann F., Michael H.Q. Methods for determining ultraviolet transmission of UV-blocking contact lenses. Int. Contact Lens Clin. 1998, 25:142-148.
43. Refojo M.F., Leong F.L. Poly(methyl acrylate-co-hydroxyethyl acrylate) hydrogel implant material of strength and softness. J. Biomed. Mater. Res. 1981, 15:497-509.
44. De Queiroz A., Franca E., Abraham G., San Roman J. Drug complexation and physicochemical properties of vinylpyrrolidone-N,N'-dimethylacrylamide copolymers. J. Appl. Polym. Sci. 2004, 93:1337-1347.
45. Valdes T.I., Kreutzer D., Moussy F. The chick chorioallantoic membrane as a novel in vivo model for the testing of biomaterials. J. Biomed. Mater. Res. 2002, 62:273-282.
46. Scheel J., Kleber M., Kreutz J., Lehringer E., Mehling A., Reisinger K., Steiling W. Eye irritation potential: usefulness of the HET-CAM under the globally harmonized system of classification and labeling of chemicals (GHS). Regul. Toxicol. Pharm. 2011, 59:471-492.
47. Kim S.W., Bae Y.H., Okano T. Hydrogels: swelling, drug loading, and release. Pharm. Res. 1992, 9:283-290.
48. Rodriguez-Tenreiro C., Alvarez-Lorenzo C., Rodriguez-Perez A., Concheiro A., Torres-Labandeira J.J. New cyclodextrin hydrogels cross-linked with diglycidylethers with a high drug loading and controlled release ability. Pharm. Res. 2006, 23:121-130.
49. Remko M., von der Lieth C.W. Theoretical study of gas-phase acidity, pKa, lipophilicity, and solubility of some biologically active sulfonamides. Bioorg. Med. Chem. 2004, 12:5395-5403.
50. Supuran C.T., Scozzafava A. Carbonic anhydrases as targets for medicinal chemistry. Bioorg. Med. Chem. 2007, 15:4336-4350.
51. Supuran C. Carbonic anhydrase inhibitors. Bioorg. Med. Chem. Lett. 2010, 20:3467-3474.
52. Loftsson T., Fri{eth}riksdóttir H., Thórisdóttir S., Stefánsson E., Sigur{eth}ardóttir A.M., Gu{eth}mundsson Ö., Sigthórsson T. 2-Hydroxypropyl-β-cyclodextrin in topical carbonic anhydrase inhibitor formulations. Eur. J. Pharm. Sci. 1994, 1:175-180.